Cited by CrossRef (5)

  1. Xue Yang, Zhiwei He, Li Yuan, Wenbin Huang, Doudou Li, Pingping Xiang, Yu Chen, Guofang Chen, Chao Liu. Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial. BMC Endocr Disord 2023;23
    https://doi.org/10.1186/s12902-023-01461-9
  2. Diego Anazco, Wissam Ghusn, Alejandro Campos, Lizeth Cifuentes, Sima Fansa, Elif Tama, Joshua T. Bublitz, Khushboo Gala, Maria D. Hurtado, Janet E. Olson, Andres Acosta. Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case–Control Study. OBES SURG 2023;33:3502
    https://doi.org/10.1007/s11695-023-06859-x
  3. Ji Yoon Kim, Nam Hoon Kim. Initial Combination Therapy in Type 2 Diabetes. Endocrinol Metab 2024;39:23
    https://doi.org/10.3803/EnM.2023.1816
  4. Xue Yang, Zhiwei He, Qilin Chen, Yu Chen, Guofang Chen, Chao Liu. Global research trends of diabetes remission: a bibliometric study. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1272651
  5. Michael Daniel, Cassandra Fritz, Tsehay Abebe, Ahmad N. Bazarbashi, Shelby Sullivan, Su-Hsin Chang, Vladimir Kushnir. Cost-effectiveness Analysis of Endoscopic Sleeve Gastroplasty. Techniques and Innovations in Gastrointestinal Endoscopy 2024
    https://doi.org/10.1016/j.tige.2024.06.001